The novel mechanism of cancer formation discovered by Dr Polly Leilei Chen...
The novel mechanism of cancer formation discovered by Dr Polly Leilei Chen (right), Dr Song Yangyang (left) and their team could lead to more effective treatment

Image source: NUS

News • RNA editing

New mechanism of cancer formation discovered

A team of scientists at the National University of Singapore (NUS) led by Dr Polly Leilei Chen from the Cancer Science Institute of Singapore and Yong Loo Lin School of Medicine has discovered a previously unknown mechanism of cancer formation, the understanding of which may lead to more effective treatment.

Their findings concern a process called RNA editing. The DNA code of a gene gets transcribed into an intermediate code known as RNA, before being translated into a protein molecule that plays a particular role in the cell. Sometimes, the RNA gets modified, or edited, before the final translation, yielding a different protein product. RNA editing is a phenomenon that gives the cell finer control over its proteins.

Their findings were published in the Journal of Hepatology.

With this new knowledge, we can now look into how A-to-I RNA editing contributes to cancer by altering their protein sequences and how we can restore cancer-suppressing processes mediated by RNA editing in the cell

Polly Leilei Chen

The research team examined the RNA encoding a protein called “coatomer subunit α” (COPA), which influences the development of cancers of the liver, esophagus, stomach and breast, and examined whether RNA transcribed from the COPA gene was edited or altered in clinical samples of cancerous liver tissues. They discovered that any given cell contains a mix of both edited and unedited versions of COPA. When the unedited or “wild type” COPA is predominant, the cell is more likely to become cancerous. Conversely, when edited COPA is predominant, it is thought to suppress a convoluted molecular signalling network called the PI3K/AKT/mTOR signalling pathway. When this pathway gets out of control, it triggers excessive cell multiplication which can lead to cancer.

The researchers are now trying to find a way to boost the natural RNA editing mechanisms in the cancerous cell to tip the balance in favour of the edited version of COPA, thereby suppressing the cancer. “With this new knowledge, we can now look into how A-to-I RNA editing contributes to cancer by altering their protein sequences and how we can restore cancer-suppressing processes mediated by RNA editing in the cell,” said Dr Chen.


Source: National University of Singapore

16.01.2021

Read all latest stories

Related articles

Photo

News • Bioprinting in cancer

3D printing patient-specific tumours

Bowel cancer patients could in future benefit from a new 3D bioprinting technology which would use their own cells to replicate the complex cellular environment of solid tumours in 3D models.

Photo

News • Stopping the spread

Research sheds new light on pancreatic cancer metastasis

With an overall survival rate of 9% for those diagnosed, pancreatic cancer remains exceedingly difficult to treat. However, the patient's primary tumor typically isn't what leads to death - it is the…

Photo

News • Cytosponge research

‘Pill on a string’ test could transform oesophageal cancer diagnosis

A ‘pill on a string’ test can identify ten times more people with Barrett’s oesophagus than the usual GP route, a new study shows. The test, which can be carried out by a nurse in a GP surgery,…

Related products

Sarstedt – Low DNA Binding Micro Tubes

Research Use Only

Sarstedt – Low DNA Binding Micro Tubes

SARSTEDT AG & CO. KG
Shimadzu – CLAM-2030 CL (IVD)/ CLAM-2030 (RUO)

Mass Spectrometry

Shimadzu – CLAM-2030 CL (IVD)/ CLAM-2030 (RUO)

Shimadzu Europa GmbH
Shimadzu – LCMS-8060NX CL (IVD) / LCMS-8060 NX (RUO)

Mass Spectrometry

Shimadzu – LCMS-8060NX CL (IVD) / LCMS-8060 NX (RUO)

Shimadzu Europa GmbH
Shimadzu – MALDImini-1

Research Use Only

Shimadzu – MALDImini-1

Shimadzu Europa GmbH
Subscribe to Newsletter